Axis Biotec

Axis Biotec Brazil Innovative, Safe and Efficacious Wound Dressing with IP Rights Approved in 11 Countries, Colzen® Treats Lesions That Are Difficult to Heal

Some wounds can be difficult to heal and the patients affected by them can suffer from infections, pain and other complications. A Brazilian product capable of revolutionizing wound treatment has already had its Intellectual Property (IP) rights approved in Germany, China, Spain, the United States,... - April 27, 2017